Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
20.54
+0.28 (1.38%)
Nov 22, 2024, 4:00 PM EST - Market closed
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for BCYC stock have an average target of 40.13, with a low estimate of 25 and a high estimate of 60. The average target predicts an increase of 95.37% from the current stock price of 20.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BCYC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Initiates $25 | Hold | Initiates | $25 | +21.71% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +70.40% | Nov 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +167.77% | Nov 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +85.00% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +167.77% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
38.39M
from 26.98M
Increased by 42.30%
Revenue Next Year
30.67M
from 38.39M
Decreased by -20.09%
EPS This Year
-3.12
from -5.08
EPS Next Year
-3.62
from -3.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 45.7M | 63.0M | 145.1M | ||
| Avg | 38.4M | 30.7M | 59.5M | ||
| Low | 33.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 69.3% | 64.1% | 373.0% | ||
| Avg | 42.3% | -20.1% | 94.0% | ||
| Low | 24.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.05 | -3.20 | -2.82 | ||
| Avg | -3.12 | -3.62 | -3.99 | ||
| Low | -3.38 | -4.18 | -4.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.